Identification of lipid metabolism-related genes in dapagliflozin treated rats with diabetic cardiomyopathy by bioinformatics
BackgroundDiabetic cardiomyopathy (DCM) is a heart disease caused by the metabolic disorders of glucose and lipids associated with diabetes, leading to heart failure and death in diabetic patients. Dapagliflozin (DAPA) serves as a treatment for managing blood glucose levels in individuals with type...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2025-03-01
|
| Reeks: | Frontiers in Endocrinology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1525831/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|